Table 2.

Patients’ clinical details according to the prescribed NOAC therapy

	Apixaban 2.5 mg BID (n=86)	Apixaban 5 mg BID (n=35)	Dabigatran 110 mg BID (n=31)	Dabigatran 150 mg BID (n=14)	Rivaroxaban 15 mg QD (n=18)	Rivaroxaban 20 mg QD (n=40)
Age, years	84.13±5.54	75.42±7.31	81.77±5.97	72.86±5.88	81.83±7.82	76.62±10.39
Weight, kg	69.28±15.39	76.11±13.7	67.65±12.15	76.97±17.97	64.86±9.56	73.99±13.98
eGFR, mL/min	46.62±15.75	72.11±24.67	54.55±20.55	87.58±28.82	54.02±21.73	73.48±22.72

Note: Values are expressed as n, total number, and mean ± SD.

Abbreviations: BID, bis in die; eGFR, estimated glomerular filtration rate; NOAC, non-vitamin K oral anticoagulant; QD, quaque die.